Pantoprazole and Dostinex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pantoprazole (pantoprazole sodium) and Dostinex (cabergoline). Common drug interactions include injection site bruising among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Pantoprazole and Dostinex. It is created by eHealthMe based on reports of 71 people who take the same drugs from the FDA, and is updated regularly.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,165 Pantoprazole users. Check the latest studies of Pantoprazole.

What is Dostinex?

Dostinex has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 3,064 Dostinex users. Check the latest studies of Dostinex.



On Jul, 11, 2026

71 people who take Pantoprazole and Dostinex together, and have interactions are studied.

Pantoprazole and Dostinex drug interactions.

What are the common drug interactions of Pantoprazole and Dostinex, by gender? *:

female:

  1. Injection site bruising
  2. Abdominal pain
  3. Anxiety
  4. Blood growth hormone increased
  5. Blood pressure decreased
  6. Blood pressure increased
  7. Blood pressure systolic increased
  8. Body temperature decreased
  9. Breast cancer
  10. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)

male:

  1. Pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Pain in extremity
  4. Plasma cell myeloma (cancer that begins in plasma cells)
  5. Spinal fracture (fracture in one of vertebrae)
  6. Spinal osteoarthritis (joint cartilage loss in spine)
  7. Therapeutic response decreased (less preventive response)
  8. Abdominal discomfort
  9. Abdominal pain
  10. Androgen deficiency

What are the common drug interactions of Pantoprazole and Dostinex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Arthralgia (joint pain)
  2. Benign neoplasm (benign (non-cancerous) tumour)
  3. Blood prolactin increased
  4. Burning sensation
  5. Cough
  6. Drug ineffective
  7. Fatigue (feeling of tiredness)
  8. Feeling jittery
  9. Headache (pain in head)
  10. Insomnia (sleeplessness)

30-39:

  1. Drug ineffective
  2. Injection site haemorrhage (bleeding from injection site)
  3. Injection site pain

40-49:

  1. Breast cancer
  2. Arthralgia (joint pain)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Mobility decreased (ability to move is reduced)
  5. Joint stiffness

50-59:

  1. Vomiting
  2. Anxiety
  3. Fatigue (feeling of tiredness)
  4. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  5. Hyperglycaemia (high blood sugar)
  6. Injection site pain
  7. Aortic dilatation
  8. Blood glucose increased
  9. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  10. Type 2 diabetes mellitus

60+:

  1. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  2. Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
  3. Blood pressure decreased
  4. Blood pressure increased
  5. Blood pressure systolic increased
  6. Body temperature decreased
  7. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Constipation
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 27 people, 38.03%
  2. Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 26 people, 36.62%
  3. Nausea (feeling of having an urge to vomit): 19 people, 26.76%
  4. Abdominal Pain Upper: 10 people, 14.08%
  5. High Blood Pressure: 8 people, 11.27%
  6. Diabetes: 8 people, 11.27%
  7. Prolactin-Producing Pituitary Tumor: 7 people, 9.86%
  8. High Blood Cholesterol: 7 people, 9.86%
  9. Stress And Anxiety: 6 people, 8.45%
  10. Joint Pain: 6 people, 8.45%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole and Dostinex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pantoprazole and Dostinex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pantoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dostinex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pantoprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dostinex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium and cabergoline (the active ingredients of Pantoprazole and Dostinex, respectively), and Pantoprazole and Dostinex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: